Park West Asset Management LLC - GALMED PHARMACEUTICALS LTD ownership

GALMED PHARMACEUTICALS LTD's ticker is GLMD and the CUSIP is M47238106. A total of 21 filers reported holding GALMED PHARMACEUTICALS LTD in Q2 2014. The put-call ratio across all filers is - and the average weighting 0.3%.

Quarter-by-quarter ownership
Park West Asset Management LLC ownership history of GALMED PHARMACEUTICALS LTD
ValueSharesWeighting
Q1 2018$2,026,000
-24.4%
363,700
+24.2%
0.09%
-26.2%
Q4 2017$2,679,000
+4.5%
292,847
+4.4%
0.12%
-20.3%
Q3 2017$2,564,000
+101.3%
280,500
+36.5%
0.15%
+115.5%
Q2 2017$1,274,000
+26.8%
205,5000.0%0.07%
+20.3%
Q1 2017$1,005,000
+39.4%
205,5000.0%0.06%
+5.4%
Q4 2016$721,000
-20.9%
205,5000.0%0.06%
-32.5%
Q3 2016$912,000
-1.2%
205,5000.0%0.08%
-10.8%
Q2 2016$923,000
-8.9%
205,5000.0%0.09%
-2.1%
Q1 2016$1,013,000
-35.2%
205,5000.0%0.10%
-43.8%
Q4 2015$1,564,000
+2.4%
205,5000.0%0.17%
+21.6%
Q3 2015$1,527,000
-24.4%
205,500
+2.3%
0.14%
-26.1%
Q2 2015$2,020,000
+6.3%
200,788
-0.5%
0.19%
-32.1%
Q1 2015$1,901,000
+62.3%
201,8480.0%0.28%
+48.9%
Q4 2014$1,171,000
-32.5%
201,8480.0%0.19%
-27.6%
Q3 2014$1,736,000
-11.7%
201,8480.0%0.26%0.0%
Q2 2014$1,966,000
-14.3%
201,848
+0.9%
0.26%
-1.5%
Q1 2014$2,294,000200,0000.26%
Other shareholders
GALMED PHARMACEUTICALS LTD shareholders Q2 2014
NameSharesValueWeighting ↓
DAFNA Capital Management LLC 202,100$2,318,0001.99%
Gerry Farber, LLC 52,000$596,0001.03%
Granite Point Capital Management, L.P. 115,000$1,319,0000.94%
683 Capital Management, LLC 158,735$1,821,0000.71%
SPHERA FUNDS MANAGEMENT LTD. 170,000$1,950,0000.44%
Knoll Capital Management, LLC 65,000$746,0000.39%
Healthcare Value Capital, LLC 50,000$574,0000.38%
Park West Asset Management LLC 200,000$2,294,0000.26%
Perceptive Advisors 75,000$860,0000.09%
HIGHLAND CAPITAL MANAGEMENT LP 126,956$1,456,0000.06%
View complete list of GALMED PHARMACEUTICALS LTD shareholders